HCP (HCP) was Upgraded by Mizuho to ” Buy” and the brokerage firm has set the Price Target at $32. Earlier the firm had a rating of “Neutral ” on the company shares. Mizuho advised their investors in a research report released on Nov 21, 2016.
Many Wall Street Analysts have commented on HCP. Mizuho Upgraded HCP on Nov 21, 2016 to ” Buy”, Price Target of the shares are set at $32.Shares were Upgraded by RBC Capital Mkts on Nov 4, 2016 to ” Sector Perform” and Lowered the Price Target to $ 30 from a previous price target of $35 .Shares were Reiterated by Mizuho on Nov 2, 2016 to “Neutral” and Lowered the Price Target to $ 31 from a previous price target of $37 .
On the company’s financial health, HCP reported $0.72 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Nov 1, 2016. Analyst had a consensus of $0.71.Analysts expectations of $ 626.34.During the same quarter in the previous year, the company posted $0.79 EPS.
HCP closed down -0.08 points or -0.28% at $28.68 with 30,52,653 shares getting traded on Monday. Post opening the session at $28.78, the shares hit an intraday low of $28.48 and an intraday high of $28.94 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
In a different news, on Sep 8, 2016, Thomas D Kirby (Executive Vice President) sold 3,000 shares at $40.24 per share price. According to the SEC, on Sep 1, 2016, Darren A Kowalske (Executive Vice President) sold 2,250 shares at $39.20 per share price. On Aug 24, 2016, Jonathan M. Bergschneider (Executive Vice President) sold 7,651 shares at $39.78 per share price, according to the Form-4 filing with the securities and exchange commission.
HCP Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing post-acute/skilled nursing life science medical office and hospital. Its portfolio includes owned portfolio unconsolidated joint ventures and developments and redevelopments. Its owned portfolio includes around 1040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing life science and medical office segments. It has assets under development redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments which are under development or redevelopment include Pacific Corporate Park Memorial Hermann Sky Ridge Bayfront Folsom and Deer Park.